Search

The Impact of Racial Disparities in the Diagnosis and Treatment of Atopic Dermatitis
Jonathan Silverberg, MD, PhD, MPH, discusses the importance of considering racial disparities in the diagnosis and treatment of atopic dermatitis on Medscape.com
Can You Get Psoriasis Behind the Knees?
Adam Friedman, MD, Professor & Chair of Dermatology, is featured in an article about if the rash behind your knees is a psoriasis flare, plus what to do to clear it up on HealthCentral.com.
Minoxidil, drug that treats thinning hair, may be in short supply
Adam Friedman, MD, Professor & Chair of Dermatology, is featured in an article about If patients can't fill prescriptions for the daily pill quickly, they may lose the hair they've regrown on NBC Health News.
Minoxidil may be in short supply. Here are 5 other hair loss treatments you can use instead.
Adam Friedman, MD, Professor & Chair of Dermatology, is featured in an article for alternatives to Minoxidil for hair growth range from prescription medications like Finasteride to natural supplements like rosemary oil. For more information please click here.
Best of 2023- Modern Aesthetics
Pooja Sodha, MD, shares which fillers, lasers, and devices she got excited about in 2023 as well as the role of combination therapies. Dr. Sodha also tells what she hopes will be The Next Big Things in 2024. To learn more, please click here.
Monitoring Immunotherapy Toxicities in CSCC and BCC
Dr. Vishal Anil Patel, MD, Director of Cutaneous Oncology and Dermatologic Surgery, is featured in an article emphasizing the role of coordinated care between dermatologists and oncologists in monitoring and managing adverse events related to immunotherapy in CSCC and BCC. For more information,…
A Phase II Study of the Safety, Tolerability and Antitumor Activity of Tucatinib in Combination With Eribulin and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer
Primary Outcome Measure: • To assess the safety and tolerability of tucatinib in combination with eribulin and trastuzumab in patients with unresectable or recurrent metastatic HER2+ breast cancer who have had prior treatment with trastuzumab, and trastuzumab deruxtecan. • Evaluate the relative…
Amarendra K. Neppalli, MD
Amarendra Neppalli, MD is a board-certified hematologist and associate professor at the GW School of Medicine and Health Sciences. He is also the chief of plasma cell disorders and director of transplant and cellular therapy at The GW Medical Faculty Associates. Dr. Neppalli takes care of patients…
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone (DPd)
Primary Outcome Measure: • Progression-Free Survival (PFS) o Time Frame: Up to 6 years 6 months
Vinh Son Tran, MD
Vinh Son Tran, MD is a board-certified family medicine physician. Dr. Tran earned his medical degree from the Eastern Virginia Medical School, and completed a family and community medicine residency training at Penn State Milton S. Hershey Medical Center.